Kidney Stones Market

The rapid adoption of Minimally Invasive Surgical (MIS) techniques by surgeons has led to a wide variety of applications. In general surgery, minimally invasive methods are being adopted more often than open surgeries. The minimal side effects of MIS procedures compared to open surgery will increase the demand for advanced procedures to manage kidney stones. 

The journal Advances in Chronic Kidney Diseases states that minimally invasive treatments have been widely used for three of the most common stone diseases in America extracorporeal, ureteroscopic, and percutaneous renal lithotomy. Procedures that were previously open to the public are now being performed by minimally invasive surgeons.

The aging population is a significant driver of the Global Global Kidney Stone Market Industry. As individuals age, the risk of developing kidney stones increases due to various factors, including changes in metabolism and dietary habits. The World Health Organization projects that the global population aged 60 years and older will reach 2.1 billion by 2050. This demographic shift is likely to result in a higher incidence of kidney stones, thereby increasing the demand for treatment options and healthcare services. Consequently, the market is poised for growth, with a projected CAGR of 5.88% from 2025 to 2035.

An increase in global healthcare expenditure is positively impacting the Global Global Kidney Stone Market Industry. As countries invest more in healthcare infrastructure and services, access to advanced diagnostic and treatment options for kidney stones improves. This trend is particularly evident in developing nations, where rising incomes and government initiatives are enhancing healthcare access. Consequently, patients are more likely to seek treatment for kidney stones, driving market growth. The overall increase in healthcare spending is expected to support the market's expansion, aligning with the projected growth trajectory.

Technological advancements in the medical field are significantly influencing the Global Global Kidney Stone Market Industry. Innovations such as minimally invasive surgical techniques, improved imaging technologies, and enhanced lithotripsy devices are transforming the treatment landscape. These advancements not only improve patient outcomes but also reduce recovery times, making procedures more appealing to patients. As a result, healthcare providers are increasingly adopting these technologies, which is expected to contribute to the market's growth trajectory, potentially reaching 5.06 USD Billion by 2035.

There is a growing emphasis on awareness and education regarding kidney stone prevention and management within the Global Global Kidney Stone Market Industry. Public health campaigns and educational initiatives are being implemented to inform individuals about risk factors, dietary modifications, and hydration practices that can help prevent kidney stones. This increased awareness is likely to lead to early diagnosis and treatment, ultimately driving market growth. As more individuals become informed about kidney stone risks, the demand for related healthcare services and products is expected to rise, supporting the market's expansion.

The Global Global Kidney Stone Market Industry is experiencing growth due to the increasing prevalence of kidney stones worldwide. Factors such as dietary habits, obesity, and dehydration contribute to this rise. According to health statistics, the incidence of kidney stones has been steadily increasing, with estimates suggesting that approximately 10 percent of the population will experience a kidney stone at some point in their lives. This growing patient population is likely to drive demand for treatment options and preventive measures, thereby expanding the market, which is projected to reach 2.7 USD Billion in 2024.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America kidney stone held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, and presence of major key companies headquarters in the region are driving the market in the region. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry development.

Further, the major countries studied are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3 KIDNEY STONE MARKET SIZE BY REGION 2022 & 2030 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe kidney stone market accounts for the second-largest market share due to the increasing prevalence of kidney stone disease and the rise in the elderly population across Europe. However, the lack of awareness regarding renal stones hinders market growth. Further, the Germany kidney stone market held the largest market share, and the UK kidney stone market was the fastest-growing market in the European region.

The Asia-Pacific kidney stone market is expected to grow at a significant growth rate during the forecast period. This is due to the rising incidence of kidney stones, the rapidly building healthcare infrastructure, the growing government support, and the rising number of startups in this region. Moreover, China kidney stone market held the largest market share, and the India kidney stone market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2024–2032.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the kidney stone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the kidney stone industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment. 

One of the primary business strategies adopted by manufacturers in the  kidney stone industry to benefit clients and expand the kidney stone market sector is to manufacture locally to reduce operating costs.

Boston Scientific Corporation (US) is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In September 2021, Boston Scientific Corporation acquired a  surgical business of Lumenis Ltd. (Israel) a privately held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA).

The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.